AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06727513 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: A double-operator technique for GlideScope intubation
Description: A double-operator technique where the senior resident will insert the GlideScope until visualizing an optimal glottic view, then the attending physician will take over the GlideScope keeping it in the same fixed position, while the resident performs the endotracheal intubation using an angulated stylet.
Study NCT06745258 — intervention group
Intervention type: OTHER
Intervention: External Facilitation
Description: Multi-component facilitation strategy to address identified implementation needs
Study NCT06741137 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: inhaled nitric oxide combined with prone position ventilation
Description: inhaled nitric oxide combined with prone position ventilation
Study NCT04983667 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Zn-AA
Description: Oral supplementation of either 30 mg daily or Zinc-AA complex or placebo, from the study recruitment during first trimester of pregnancy, all through pregnancy and up to the sixth month after giving birth.
Study NCT04983667 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Zn-AA
Description: Oral supplementation of either 30 mg daily or Zinc-AA complex or placebo, from the study recruitment during first trimester of pregnancy, all through pregnancy and up to the sixth month after giving birth.
Study NCT06451562 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lidocaine
Description: a local anesthetic drug of the amino amide type
Study NCT05340933 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Voice registration
Description: Voice registration
Study NCT06017752 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: STAC Teacher Module
Description: The STAC Teacher Module is a 30-minute presentation that includes normative feedback, didactic information, a review of the student STAC strategies and corresponding strategies teachers can use to support students who act as defenders, and information about perceptions vs. facts about bullying.
Study NCT05558098 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dapagliflozin 10mg Tab
Description: Dapagliflozin 10 mg once per day for 14 days or until intensive care unit discharge or death
Study NCT05558098 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care
Description: Current standard of care for management of critically ill patients
Study NCT05144802 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: acute hypoxia
Description: Participants will be exposed to a 3-hour acute hypoxia
Study NCT05144802 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: acute hypoxia
Description: Participants will be exposed to a 3-hour acute hypoxia
Study NCT05538975 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physiotherapy Treatment
Description: Pulmonary Rehabilitation Techniques
Study NCT05538975 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Physiotherapy Treatment
Description: Pulmonary Rehabilitation Techniques
Study NCT06764914 — intervention group
Intervention type: OTHER
Intervention: integrative and complementary medicine
Description: Treatment with integrative and complementary methods for both, inpatients and outpatients, includes conventional therapy, integrative methods and ordinal therapy/MBM, which are individually designed for each patient. Similar to a shedule, with therapy units from the following areas: hydrotherapy/thermotherapy, exercise therapy, physiotherapy, nutritional therapy and bodywork therapy, supplemented as required by phytotherapeutic and other therapies, such as acupuncture, neural therapy and cupping. After inpatient treatment, patients can receive up to 10 additional outpatient treatments at our TCM outpatient clinic. There is also a 10-week programme for day patients. This focuses on ordinal therapy to achieve sustainable, balanced lifestyle changes. This includes classic acupuncture and drainage techniques such as Gua Sha (connective tissue massage in TCM) or cupping, as well as neural therapy, electro-acupuncture and others. Daily medical visits and self-care advice are also included.
Study NCT06765109 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NVL-655
Description: Oral tablet of NVL-655
Study NCT06765109 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Alectinib
Description: Oral capsule of alectinib
Study NCT06767085 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lidocaine-Prilocaine Topical
Description: lidocaine-prilocaine spray on the cervix and cervical canal 5-7 minutes prior to the procedure
Study NCT06767085 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Saline spray
Description: saline spray on the cervix and cervical canal 5-7 minutes prior to the procedure
Study NCT06765421 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intervention Group
Description: Intervention group activity involves three components:~1. Intervention group GPs will be provided with a long COVID 'toolkit'. The toolkit will be prepared by the study team in collaboration with expert clinicians and public and patient representatives as a resource for GPs to use in patient care.~2. GPs will attend an expert clinician / patient led long COVID educational session grounded in the findings of the toolkit.~3. Applying learnings to date, each GP will conduct case reviews of eight patients with long COVID attending their practice and provide patient care as appropriate.
Study NCT06762756 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Messages on tobacco packaging labels
Description: The intervention was messages of the benefits of smoking cessation formatted as tobacco packaging labels with three conditions. Participants viewed the messages online. There were four messages in each condition. The intervention was informed by relevant patient and public groups.
Study NCT06762756 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Messages on tobacco packaging labels
Description: The intervention was messages of the benefits of smoking cessation formatted as tobacco packaging labels with three conditions. Participants viewed the messages online. There were four messages in each condition. The intervention was informed by relevant patient and public groups.
Study NCT06762756 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Messages on tobacco packaging labels
Description: The intervention was messages of the benefits of smoking cessation formatted as tobacco packaging labels with three conditions. Participants viewed the messages online. There were four messages in each condition. The intervention was informed by relevant patient and public groups.
Study NCT05582135 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 2 mg morphine sulfate
Description: The parturients were administered 2 mg morphine sulfate through the epidural catheter. Sterile saline was added to make a total volume of 8 mL.
Study NCT05582135 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 0.25mg/kg esketamine
Description: The parturients were administered 0.25mg/kg of esketamine through the epidural catheter. Sterile saline was added to make a total volume of 8 mL.
Study NCT05582135 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 0.25mg/kg of esketamine in combination with 2 mg morphine sulfate
Description: The parturients were administered 0.25mg/kg of esketamine in combination with 2 mg morphine sulfate through the epidural catheter. Sterile saline was added to all combinations of the analgesic drugs to make a total volume of 8 mL.
Study NCT05582135 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 0.25mg/kg of esketamine in combination with 1 mg morphine sulfate
Description: The parturients were administered 0.25mg/kg of esketamine in combination with 1 mg morphine sulfate through the epidural catheter. Sterile saline was added to all combinations of the analgesic drugs to make a total volume of 8 mL.
Study NCT05596149 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Toothpaste without fluoride
Description: A sample of cells from the area of the buccal mucosa of each of the subjects will be taken with a cytological brush just before the start of using the toothpaste without fluoride and 30, 45 and 60 days after the start of use. Cell suspension is applied on a microscopy slide. Slides will be stained with Fast Green FCF dye and analyzed with an epifluorescence microscope. After using each tested toothpaste, the respondents will be given a specially designed questionnaire with questions related to their opinion about the used oral hygiene product.
Study NCT05596149 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Toothpaste with sodium fluoride
Description: A sample of cells from the area of the buccal mucosa of each of the subjects will be taken with a cytological brush just before the start of using the toothpaste with sodium fluoride and 30, 45 and 60 days after the start of use. Cell suspension is applied on a microscopy slide. Slides will be stained with Fast Green FCF dye and analyzed with an epifluorescence microscope. After using each tested toothpaste, the respondents will be given a specially designed questionnaire with questions related to their opinion about the used oral hygiene product.
Study NCT05596149 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Toothpaste with sodium monofluorophosphate
Description: A sample of cells from the area of the buccal mucosa of each of the subjects will be taken with a cytological brush just before the start of using the toothpaste with sodium monofluorophosphate and 30, 45 and 60 days after the start of use. Cell suspension is applied on a microscopy slide. Slides will be stained with Fast Green FCF dye and analyzed with an epifluorescence microscope. After using each tested toothpaste, the respondents will be given a specially designed questionnaire with questions related to their opinion about the used oral hygiene product.
Study NCT06769581 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Infraclavicular Brachial Plexus Blocks
Description: Lateral sagittal technique infraclavicular brachial plexus block
Study NCT06769581 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Infraclavicular Brachial Plexus Blocks
Description: Lateral sagittal technique infraclavicular brachial plexus block
Study NCT06769568 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: reduced-dose conditioning regimen containing TBI in hematopoietic stem cell transplantation treating elderly patients with aplastic anemia
Description: reduced-dose conditioning regimen containing TBI in hematopoietic stem cell transplantation treating elderly patients with aplastic anemia
Study NCT06768112 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Non-Invasive Vagus Nerve Stimulation
Description: Using non-invasive vagus nerve stimulation at the ear to stimulate the adrenergic and serum hormone pathways, activating the frontal lobe system, sensory-motor nervous system, and cerebellum, to investigate the effects and neural mechanisms of dynamic posture training and learning.
Study NCT06768112 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: balance training
Description: Participants will be asked to stand on a soft-platform and hit on blaze-pod LED within 60 seconds.
Study NCT06768112 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: balance training
Description: Participants will be asked to stand on a soft-platform and hit on blaze-pod LED within 60 seconds.
Study NCT06768112 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Mini-Mental State Examination
Description: The mini-mental state examination (MMSE) or Folstein test is a 30-point questionnaire that is used extensively in clinical and research settings to measure cognitive impairment.
Study NCT06768112 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mini-Mental State Examination
Description: The mini-mental state examination (MMSE) or Folstein test is a 30-point questionnaire that is used extensively in clinical and research settings to measure cognitive impairment.
Study NCT05596149 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Toothpaste with amine fluoride
Description: A sample of cells from the area of the buccal mucosa of each of the subjects will be taken with a cytological brush just before the start of using the toothpaste with amine fluoride and 30, 45 and 60 days after the start of use. Cell suspension is applied on a microscopy slide. Slides will be stained with Fast Green FCF dye and analyzed with an epifluorescence microscope. After using each tested toothpaste, the respondents will be given a specially designed questionnaire with questions related to their opinion about the used oral hygiene product.
Study NCT06769035 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Cocoa, amaranth seed and ginger
Description: Sachet with 20gr of cocoa, 10g of amaranth seed and 1g of ginger, one dose per day for 12 weeks
Study NCT06769035 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Amaranth seed
Description: Sachet with 10g of amaranth seed one dose per day for 12 weeks
Study NCT06769035 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Cocoa
Description: Sachet with 20gr of cocoa one dose per day for 12 weeks
Study NCT06769035 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Sachet with coloring and flavoring, one dose per day for 12 weeks one dose per day for 12 weeks
Study NCT06768424 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Guided biofilm therapy
Description: Use of Airflow Plus powder subgingivally on teeth with deep periodeontal pockets
Study NCT06768424 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Guided biofilm therapy
Description: Use of Airflow Plus powder subgingivally on teeth with deep periodeontal pockets
Study NCT06768424 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Platelet Rich Fibrin
Description: Pack Platelet Rich Fibrin chops into the intrabony periodontla defect
Study NCT06768424 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Minimally Invasive Surgical Technique
Description: Periodontal intrabony defect is treated by minimally invasive surgical intervention
Study NCT06768697 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: KFD1(0µg )
Description: SARS-CoV-2 subunit mucosal vaccine adjuvanted with flagellin protein(0µg + 80µg)
Study NCT06768697 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: KFD1(20µg)
Description: SARS-CoV-2 subunit mucosal vaccine adjuvanted with flagellin protein(20µg + 80µg)
Study NCT06768697 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: KFD1(40µg)
Description: SARS-CoV-2 subunit mucosal vaccine adjuvanted with flagellin protein(40µg + 80µg)
Study NCT06768697 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: KFD1(80µg)
Description: SARS-CoV-2 subunit mucosal vaccine adjuvanted with flagellin protein(80µg + 80µg)
Study NCT06769360 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: PMI-targeted PSV setting
Description: The pressure support is adjusted according to PMI between 0 and 2 cmH2O. After application of PSV mode in mechanically ventilated patients, the initial PS level was first set based on respiratory rate (RR) \<35 beats/min and 6-8 ml/Kg tidal volume (Vt) per predict body weight (PBW), and then modified according to PMI at a frequency of twice a day (morning and afternoon bedside rounds)# 1) Perform three end- inspiratory occlusions, with at least 1 minute between each measurement, and calculate the mean PMI. 2) Determine whether the PMI is within the target range (0≤PMI≤2cmH2O). 3) If the PMI is not within the target range, adjust the PS level up or down by 1-3 cmH2O and balance for 3-5 minutes. 4) Repeat the above steps until PMI reaches the target. 5) Additional: During PS adjustment, if Vt≤4ml/Kg, respiratory acidosis, respiratory distress, Vt≥8ml/Kg, respiratory alkalosis occurs, return to the safe PS level before adjustment and optimize other treatments.
Study NCT06769360 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: VT/RR-targeted PSV setting
Description: Standard of care: the pressure support is adjusted to obtain a VT between 6 and 8 ml/kg PBW and RR between 20 and 35 breaths/min.
Study NCT06767865 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: online support programe
Description: Individuals in the experimental group received online training and were subsequently provided with continuous follow-up, counseling, motivation and informative message support for three months. In addition, patients were given a target board containing a daily diabetes management program and were asked to use it for three months.
Study NCT06765655 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Insulin Lispro Injection
Description: point-of-care glucose monitoring via fingerstick perioperatively
Study NCT06765655 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: glucose testing
Description: POCT glucose testing via fingerstick
Study NCT04662866 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Metformin capsule 500 mg, Empagliflozin encapsulated tablet 10 mg, Pioglitazone encapsulated tablet 30 mg, Linagliptin encapsulated tablet 5 mg
Description: Comparison of 4 different antihyperglycemic drugs
Study NCT06174038 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Hearing Intervention
Description: The hearing intervention includes an auditory needs assessment, hearing aid fitting, establishing Bluetooth connectivity from hearing aids to devices such as smartphones and computers, systematic orientation and instruction in device use, and provision and discussion of hearing toolkit materials for self-management and communication strategies. The hearing intervention is person-centered, focusing on identification of individual needs, setting of specific goals, engagement in shared-informed decision-making, and development of self-management abilities. Intervention-centric outcomes (e.g., hearing aid data logging, real ear measures) to verify the best-practices intervention will be gathered at all 5 intervention sessions as well as weeks 16 and 52. Additional visits to troubleshoot hearing aids or address concerns will be scheduled as needed.
Study NCT06174038 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Health Education Intervention
Description: The evidence-based interactive health education program is designed for older adults and addresses chronic disease and disability prevention. Session content will be individualized for each participant based on a key, depending on his/her goals/interests. The curriculum includes didactics, activities, and goal setting led by staff trained/certified to deliver the intervention.
Study NCT06768242 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Cone beam CT
Description: Each patient will undergo three cone beam CTs per session, and a total of three sessions.
Study NCT06765551 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Neuromuscular Ultrasound
Description: Non-invasive ultrasound of peripheral muscles of the upper and lower extremities with additional artificiall intelligence processing of ultrasound images.
Study NCT06230458 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: FeNO-test
Description: Fractional Exhaled Nitric Oxide (FeNO)- test
Study NCT03177889 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Traditional Chinese Medicine (TCM)
Description: Traditional Chinese Medicine plus oral mucolytics \[ambroxol 30mg tid, or N-acetylcysteine 0.2g tid, serrapeptase 10mg tid, or carbocisteine 500mg tid\];~Agastache rugosus 5g, Scutellaria baicalensis 10g, Radix Puerariae 10g, Acorus tatarinowii schott 10g, Fructus Liquidambaris 5g, gypsum 15 g, Rheum officinale 5 g, Folium sennae 5 g, Codonopsis pilosula 10g, Radix Salviae Miltiorrhizae 10g, Lignum millettiae 10 g, Liquiritia glycyrrhiza 10 g~Optional formulae: bile arisaema 15g, polygala tenuifolia 15g, Mangnolia officinalis 10g, Fructus aurantii immaturus 10g; Magnetite 15-30g and reddle15-30g
Study NCT03177889 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: SHAM_COMPARATOR
Intervention: Traditional Chinese Medicine (TCM)
Description: Traditional Chinese Medicine plus oral mucolytics \[ambroxol 30mg tid, or N-acetylcysteine 0.2g tid, serrapeptase 10mg tid, or carbocisteine 500mg tid\];~Agastache rugosus 5g, Scutellaria baicalensis 10g, Radix Puerariae 10g, Acorus tatarinowii schott 10g, Fructus Liquidambaris 5g, gypsum 15 g, Rheum officinale 5 g, Folium sennae 5 g, Codonopsis pilosula 10g, Radix Salviae Miltiorrhizae 10g, Lignum millettiae 10 g, Liquiritia glycyrrhiza 10 g~Optional formulae: bile arisaema 15g, polygala tenuifolia 15g, Mangnolia officinalis 10g, Fructus aurantii immaturus 10g; Magnetite 15-30g and reddle15-30g
Study NCT04859153 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: central nerve sensory, motor control and various muscle mechanical characteristic and sport-related fitness test
Description: To explore the sports performance of the adolescent sprinters, including analyzing the correlations between the results and central nerve sensory, and also between motor control and various muscle mechanical characteristic and sport-related fitness factor.
Study NCT04827628 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Oryza Sativa Extract
Description: The product is a suspension of 5.6 gram/100 mL given once daily, contains 71.9%, purple in color, range pH 3-5. Stored in the darker bottle. The frequency of administration is once-daily after the meal.
Study NCT04827628 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: citric acid 0.1g/oz and 1% sorbitol mixture, given once daily after meal
Study NCT05451953 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Apneic Oxygenation
Description: Nasal cannula at a rate of 6L/min with 100% FiO2 during laryngoscopy and intubation attempt(s)